Danish Packaging Stock News

CPSE:ROCK B
CPSE:ROCK BBuilding

Are Rockwool (CPSE:ROCK B) Shares Pricing In Mixed Long Term Returns?

If you are wondering whether Rockwool is attractively priced or just fairly rated at its current level, you are in the right place to get a clear, numbers-first view. The share price recently closed at DKK 224.1, with returns of 4.9% over 7 days, 0.1% over 30 days, slightly negative year to date at 0.1%, and longer-term returns of a 15.9% decline over 1 year, 38.1% over 3 years and 8.3% over 5 years. Recent coverage around Rockwool has mainly focused on its position within the capital goods...
CPSE:DANSKE
CPSE:DANSKEBanks

Danske Bank (CPSE:DANSKE) Margin Slippage Challenges Stable Nordic Bank Narrative

Danske Bank (CPSE:DANSKE) has wrapped up FY 2025 with fourth quarter revenue of DKK 15.2b and basic EPS of DKK 7.73, supported by trailing twelve month revenue of DKK 56.5b and EPS of DKK 27.94 that frame the latest print in a wider earnings run rate. That backdrop of steady headline revenue and EPS trends sets up a results season where the key question for you is how far the current profitability mix, including modestly softer margins, aligns with the rewards and risks already on your...
CPSE:NNIT
CPSE:NNITHealthcare Services

NNIT (CPSE:NNIT) Loss In H1 2025 Tests Bullish Earnings Recovery Narratives

NNIT (CPSE:NNIT) has just posted its FY 2025 first half results, reporting revenue of DKK 926 million and a basic EPS loss of DKK 0.44, while net income excluding extra items came in at a loss of DKK 11 million. The company recorded revenue of DKK 937 million and net income of DKK 34 million in the first half of 2024, followed by revenue of DKK 914 million and a loss of DKK 33 million in the second half of 2024. This sets up FY 2025 against a mixed backdrop for both top line and earnings. For...
CPSE:PNDORA
CPSE:PNDORALuxury

Pandora’s Platinum Pivot Puts Product Execution And Valuation In Focus

Pandora (CPSE:PNDORA) is shifting its core jewelry offering from silver based products to platinum plated pieces, aiming to reduce exposure to swings in silver prices. The company is pausing its share buyback program as it reallocates capital toward this product overhaul. Pandora is also reshaping its leadership team, including the appointment of a new chief product officer, to support the transition. Pandora, known globally for its charm bracelets and accessible jewelry, is moving its...
CPSE:ORSTED
CPSE:ORSTEDRenewable Energy

Assessing Ørsted (CPSE:ORSTED) Valuation After Recent Share Price Rebound And DCF Discount

Recent share performance and business snapshot Ørsted (CPSE:ORSTED) has recently attracted attention after a period of mixed share performance, with the stock showing gains over the past week, month and past 3 months despite weaker longer term returns. The company operates across three main segments: Offshore, Onshore and Bioenergy & Other. It develops and runs wind, solar, energy storage, renewable hydrogen and bioenergy assets in Europe, the United States and the Asia Pacific region. See...
CPSE:DEMANT
CPSE:DEMANTMedical Equipment

Assessing Demant (CPSE:DEMANT) Valuation After Job Cuts And Cautious 2026 Outlook

Demant (CPSE:DEMANT) has drawn fresh attention after its 2025 results combined softer net income with a cautious 2026 outlook and a plan to cut 700 jobs, prompting a sharp share price reaction. See our latest analysis for Demant. The latest earnings announcement, cautious 2026 guidance and cost saving plan have come on top of a weak run for the shares, with a 7 day share price return of 14.61% decline and a 1 year total shareholder return of 28.98% decline pointing to fading momentum. If...
CPSE:CARL B
CPSE:CARL BBeverage

Carlsberg (CPSE:CARL B) Margin Compression Challenges Bullish Earnings Growth Narratives

Carlsberg (CPSE:CARL B) has posted its FY 2025 numbers with second half revenue of DKK 43.2b, basic EPS of DKK 18.10 and net income of DKK 2,393m, while the first half delivered revenue of DKK 45.9b, basic EPS of DKK 26.95 and net income of DKK 3,562m. The company has seen first half revenue move from DKK 38.8b in 2024 with basic EPS of DKK 28.08 and net income of DKK 3,739m to DKK 45.9b in 2025, which sets the scene for investors to focus on how current margins and expectations for future...
CPSE:GN
CPSE:GNConsumer Durables

GN Store Nord (CPSE:GN) Margin Compression Reinforces Bearish Earnings Narrative

GN Store Nord (CPSE:GN) closed out FY 2025 with Q4 revenue of DKK 4.7b and basic EPS of DKK 2.36, against a trailing twelve month tally of DKK 16.8b in revenue and EPS of DKK 4.48. Over recent quarters, the company has seen revenue move between DKK 3.96b and DKK 4.7b per quarter, while quarterly EPS has ranged from DKK 0.49 to DKK 2.36. This sets up a mixed picture on earnings momentum, with a clear focus on how efficiently that revenue is turning into profit. For investors, the latest print...
CPSE:MATAS
CPSE:MATASSpecialty Retail

Matas (CPSE:MATAS) Margin Improvement And 42.8% EPS Growth Test Cautious Narratives

Matas (CPSE:MATAS) has just posted Q3 2026 results with revenue of DKK2.8b and net income of DKK186m, translating to EPS of DKK4.95, while same store sales growth came in at 2.3%. The company has seen quarterly revenue move from DKK2.7b in Q3 2025 to DKK2.8b in Q3 2026, with EPS shifting from DKK5.30 to DKK4.95 over the same period. This sets the stage for investors to focus on how margins and profit quality shape the story behind this quarter’s print. See our full analysis for Matas. With...
CPSE:SOLAR B
CPSE:SOLAR BTrade Distributors

Solar (CPSE:SOLAR B) Q4 EPS Rebound Tests Bearish Thin Margin Narrative

Solar (CPSE:SOLAR B) FY 2025 earnings recap Solar (CPSE:SOLAR B) has just wrapped up FY 2025 with Q4 revenue of DKK 3.1b and basic EPS of DKK 13.01, while trailing twelve month revenue came in at DKK 12.2b and EPS at DKK 10.02. Over recent quarters the company has seen quarterly revenue move between DKK 2.8b and DKK 3.2b, with basic EPS ranging from a loss of DKK 3.70 in Q1 2025 to DKK 13.01 in Q4 2025. This leaves investors focused on how thin reported margins and the impact of past losses...
CPSE:DJUR
CPSE:DJURBanks

Djurslands Bank (CPSE:DJUR) Earnings Slowdown To 1.1% Tests Long Term Growth Narrative

Djurslands Bank (CPSE:DJUR) just wrapped up FY 2025 with fourth quarter total revenue of 173.9m DKK and net income of 64.5m DKK, alongside trailing twelve month revenue of 703.0m DKK and net income of 249.8m DKK that frame the latest numbers in a broader earnings season context. Over recent periods, the bank has seen quarterly revenue move between 157.1m DKK and 198.1m DKK with net income ranging from 45.4m DKK to 83.6m DKK. Trailing twelve month net profit margin sits at 35.5% against 36.6%...
CPSE:JYSK
CPSE:JYSKBanks

Is It Too Late To Consider Jyske Bank (CPSE:JYSK) After A 308% Five-Year Run?

If you are wondering whether Jyske Bank’s share price still offers value after a strong run, this article will walk through what the current market price may be implying. The stock last closed at DKK 943.5, with returns of 3.7% over 7 days, 6.4% over 30 days, 7.5% year to date, 86.1% over 1 year, 85.6% over 3 years, and 308.2% over 5 years, which naturally raises questions about how much of the story is already reflected in the price. Recent attention on Jyske Bank has focused on its...
CPSE:DSV
CPSE:DSVLogistics

DSV (CPSE:DSV) Margin Compression Challenges Bullish Narratives After FY 2025 Results

DSV (CPSE:DSV) has wrapped up FY 2025 with fourth quarter revenue of DKK 71.7b and basic EPS of DKK 4.72. Trailing 12 month revenue stands at DKK 247.3b with EPS of DKK 35.57. The company has seen quarterly revenue move from DKK 43.5b in Q4 2024 to DKK 71.7b in Q4 2025, with basic EPS shifting from DKK 9.46 to DKK 4.72 over the same period. Trailing net profit margin sits at 3.4% versus 6% a year earlier. Overall, the print points to healthy top line scale but thinner margins that keep the...
CPSE:NOVO B
CPSE:NOVO BPharmaceuticals

Is Novo Nordisk (CPSE:NOVO B) Now A Potential Opportunity After Sharp Share Price Drop

If you are wondering whether Novo Nordisk’s share price now reflects fair value or an opportunity, you are not alone. This article is built to help you size that up clearly. The stock last closed at DKK 280.65, with returns of 24.2% decline over 7 days, 22.9% decline over 30 days, 15.0% decline year to date, 54.5% decline over 1 year, and 38.9% decline over 3 years, while still showing a 36.1% gain over 5 years. Recent news coverage has focused heavily on Novo Nordisk’s role in diabetes and...
CPSE:VWS
CPSE:VWSElectrical

Is It Time To Reassess Vestas Wind Systems (CPSE:VWS) After Recent Share Price Pullback?

If you are wondering whether Vestas Wind Systems is still attractively priced after its recent run, this article will help you unpack what the current share price might be implying about future expectations. The stock trades at DKK 176.4 after a 6.1% decline over the last 7 days and a 5.8% decline over the last 30 days, although the 1 year return sits at 65.9%. These moves come as Vestas continues to be a focal point in global wind power discussions, with investors paying close attention to...
CPSE:CARL B
CPSE:CARL BBeverage

Does Carlsberg (CPSE:CARL B) Offer Value After Recent Share Price Strength

Wondering whether Carlsberg’s current share price really reflects what you are getting as an investor? This article walks through the numbers so you can judge the value for yourself. Carlsberg’s shares last closed at DKK 939.0, with returns of 10.2% over 7 days, 13.5% over 30 days, 13.7% year to date, 22.2% over 1 year, 5.9% over 3 years and 11.7% over 5 years. This provides useful context before thinking about what the stock might be worth. Recent coverage around Carlsberg has focused on...
CPSE:DSV
CPSE:DSVLogistics

Assessing DSV (CPSE:DSV) Valuation After Solid 2025 Results And New 2026 Synergy Guidance

DSV (CPSE:DSV) is in focus after reporting full year 2025 earnings that were broadly in line with guidance, alongside fresh 2026 EBIT guidance that factors in meaningful Schenker integration synergies. See our latest analysis for DSV. Alongside the 2025 earnings and fresh 2026 EBIT guidance, DSV’s share price has been strong, with a 30 day share price return of 13.42% and a 90 day gain of 31.65%. The 1 year total shareholder return of 31.15% and 5 year total shareholder return of 84.99% point...
CPSE:EMBLA
CPSE:EMBLAMedical Equipment

Embla Medical Hf (CPSE:EMBLA) TTM Earnings Growth Slows Against Bullish Long Term Narrative

Embla Medical hf (CPSE:EMBLA) has wrapped up FY 2025 with fourth quarter revenue of US$256.7 million and basic EPS of US$0.058, on trailing twelve month revenue of US$928.7 million and EPS of US$0.196 that frame the latest print. Over recent periods the company has seen revenue move from US$224.8 million and EPS of roughly US$0.044 in Q4 2024 to US$256.7 million and EPS of US$0.058 in Q4 2025, with trailing net income rising from US$68.3 million to US$83.3 million. This sets up a story where...
CPSE:DEMANT
CPSE:DEMANTMedical Equipment

Why Demant (CPSE:DEMANT) Is Down 11.5% After Higher 2025 Sales But Weaker EPS Performance

Demant A/S has released its full-year 2025 results, reporting sales of DKK 22,971 million, up from DKK 22,419 million a year earlier, while net income fell to DKK 1,545 million and basic earnings per share from continuing operations declined to DKK 11.2. The combination of higher sales but lower net income and earnings per share highlights shifting cost, margin or mix effects that may reshape how investors view Demant’s underlying earnings quality. We’ll now examine how Demant’s higher sales...
CPSE:ISS
CPSE:ISSCommercial Services

Assessing ISS (CPSE:ISS) Valuation After Major Swiss Life Sciences Services Contract Win

ISS (CPSE:ISS) has secured a full Integrated Facility Services contract with a major life sciences and pharmaceutical client in Switzerland, valued at nearly DKK 300 million annually across four locations. See our latest analysis for ISS. The contract win comes as ISS shares trade at DKK245.2, with a 30 day share price return of 13.73% and a 90 day gain of 19.49%. The 1 year total shareholder return of 81.37% and 5 year total shareholder return of 142.04% point to strong momentum that recent...
CPSE:DANSKE
CPSE:DANSKEBanks

Is Danske Bank’s DKK 5 Billion Buyback And Share Cancellation Altering The Investment Case For Danske Bank (CPSE:DANSKE)?

Danske Bank has completed its DKK 5,000,000,000 share buy-back programme, repurchasing 19,179,623 shares that are expected to be cancelled subject to shareholder approval at the March 26, 2026 annual general meeting. This move underscores a capital position that allows meaningful cash returns to investors and signals management’s confidence in the bank’s current trajectory. We’ll now examine how the completed DKK 5,000,000,000 buy-back and planned share cancellation shape Danske Bank’s...